Literature DB >> 9832686

Surgery for thoracic esophageal carcinoma with clinically positive cervical nodes.

Y Tachimori1, H Kato, H Watanabe.   

Abstract

OBJECTIVE: We attempted to determine whether and under what circumstances surgical intervention should be recommended for patients with clinically positive cervical nodes for metastasis from thoracic esophageal carcinoma by pretreatment examination.
METHODS: The survival of the patients was compared using factors including anatomic subsites of the tumor, T categories, subdivisions of N categories, and R classification according to the TNM classification.
RESULTS: The 5-year survival of 63 patients who underwent surgery for primary therapy was 26.7%. There was no statistically significant difference between the postoperative survivals when compared according to the location of the tumors. As a matter of course, the patients with later stages of the disease had worse survival. However, by the multivariable analysis, significant difference was recognized between the patients with tumor invading adjacent structures (T4) and those without and between the patients who received curative resection and those who did not. The 5-year survival of 47 patients who underwent surgery without residual tumor was 32.9%.
CONCLUSION: Even when the patient had clinically positive cervical nodes from thoracic esophageal carcinoma, they had a possibility of long-term survival after curative resection with neck lymph node dissection. An operation is thus indicated for curative intent. Accurate pretreatment evaluation is important when deciding which patients require surgery and how to carry out a curative surgical procedure without residual tumor.

Entities:  

Mesh:

Year:  1998        PMID: 9832686     DOI: 10.1016/S0022-5223(98)70046-7

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

Review 1.  Pattern of lymph node metastases of squamous cell esophageal cancer based on the anatomical lymphatic drainage system: efficacy of lymph node dissection according to tumor location.

Authors:  Yuji Tachimori
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

2.  Long-term survival after three-field lymph-adenectomy for an adenocarcinoma in Barrett's esophagus with metastasis to Virchow's node.

Authors:  Satoru Matono; Hiromasa Fujita; Susumu Sueyoshi; Toshiaki Tanaka; Hideaki Yamana; Kazuo Shirouzu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-01

3.  Proposed modifications of supraclavicular lymph node metastasis in the esophageal squamous cell carcinoma staging system for improved survival stratification.

Authors:  Yuzhen Zheng; Zhen Wang; Feng Wang; Qingyuan Huang; Shuoyan Liu
Journal:  Oncotarget       Date:  2017-06-20

4.  The clinical impact of supraclavicular lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.

Authors:  Yen-Hao Chen; Hung-I Lu; Chien-Ming Lo; Yu-Ming Wang; Shang-Yu Chou; Cheng-Hua Huang; Li-Hsueh Shih; Su-Wei Chen; Shau-Hsuan Li
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

5.  Analysis of definitive chemo-radiotherapy for esophageal cancer with supra-clavicular node metastasis based on CT in a single institutional retrospective study: a propensity score matching analysis.

Authors:  Hong-Yao Xu; Sheng-Xi Wu; He-San Luo; Chu-Yun Chen; Lian-Xing Lin; He-Cheng Huang
Journal:  Radiat Oncol       Date:  2018-10-16       Impact factor: 3.481

6.  Neoadjuvant therapy combined with surgery is superior to chemoradiotherapy in esophageal squamous cell cancer patients with resectable supraclavicular lymph node metastasis: a propensity score-matched analysis.

Authors:  Yongkui Yu; Lei Xu; Xiankai Chen; Haomiao Li; Qi Liu; Ruixiang Zhang; Hounai Xie; Yongfeng Chen; Ling Yuan; Bo Tan; Yin Li; Wenqun Xing
Journal:  Ann Transl Med       Date:  2022-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.